These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1197384)
41. Quantitative structure-activity relationships of chymotrypsin. On the predictive value of correlation equations. Grieco C; Silipo C; Vittoria A; Hansch C J Med Chem; 1977 Apr; 20(4):586-8. PubMed ID: 850244 [No Abstract] [Full Text] [Related]
42. Inhibition of chymotrypsin A-alpha with N-acyl- and N-peptidyl-2-phenylethyl amines. Subsite binding free energies. Powers JC; Baker BL; Brown J; Chelm BK J Am Chem Soc; 1974 Jan; 96(1):238-43. PubMed ID: 4810569 [No Abstract] [Full Text] [Related]
43. Kinetics of inactivation of alpha-chymotrypsin with substituted benzenesulfonyl fluorides. Gerig JT; Roe DC J Am Chem Soc; 1974 Jan; 96(1):233-8. PubMed ID: 4810568 [No Abstract] [Full Text] [Related]
44. Solute transfer between intramolecular polar and non-polar phases as a possible rate-limiting step in chymotrypsin deacylation. Coe EL; Coe MH J Theor Biol; 1970 Dec; 29(3):411-25. PubMed ID: 5492995 [No Abstract] [Full Text] [Related]
46. On the correlation between three-dimensional structure and reactivity for a series of locked substrates of chymotrypsin. Rodgers PS; Goaman LC; Blow DM J Am Chem Soc; 1976 Oct; 98(21):6690-5. PubMed ID: 972222 [No Abstract] [Full Text] [Related]
47. NMR evidence against covalent attachment of an aldehyde 'transition-state' analogue to alpha-chymotrypsin. Gorenstein DG; Kar D; Momii RK Biochem Biophys Res Commun; 1976 Nov; 73(1):105-11. PubMed ID: 999692 [No Abstract] [Full Text] [Related]
48. Quantum-chemical study of chymotrypsin primary specificity. Banacký P Biophys Chem; 1980 Aug; 12(1):13-9. PubMed ID: 7437497 [No Abstract] [Full Text] [Related]
49. Interpretation of thermodynamic compensation plots for acyl alpha-chymotrypsin systems. Adams PA Biochem J; 1981 Aug; 197(2):527-8. PubMed ID: 7325973 [No Abstract] [Full Text] [Related]
50. Consideration of kinetic data on alpha-chymotrypsin in terms of oligomer activities. Winzor DJ; Loke JP; Nichol LW Biochem J; 1968 Jun; 108(1):159-60. PubMed ID: 5657449 [No Abstract] [Full Text] [Related]
51. The theory of multi-stationary state transitions and biosynthetic control processes. Lavenda BH Q Rev Biophys; 1972 Nov; 5(4):429-79. PubMed ID: 4570800 [No Abstract] [Full Text] [Related]
52. Substrate induced pK perturbations with chymotrypsin and the possible significance of nonproductive binding. Zeeberg B; Caplow M; Caswell M J Am Chem Soc; 1975 Dec; 97(25):7346-52. PubMed ID: 1194602 [No Abstract] [Full Text] [Related]
53. Chymotrypsin compensation plots: a cautionary note. Klapper MH; Calvo KC; Wang CA Biochem J; 1981 Aug; 197(2):527. PubMed ID: 7325972 [No Abstract] [Full Text] [Related]
54. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin. Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737 [TBL] [Abstract][Full Text] [Related]
55. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding. Itzhaki LS; Otzen DE; Fersht AR J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748 [TBL] [Abstract][Full Text] [Related]
56. Surfactant solutions and porous substrates: spreading and imbibition. Starov VM Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660 [TBL] [Abstract][Full Text] [Related]
57. Kinetics and thermodynamics of the slow hydrophobic deactivation of alpha-chymotrypsin. Smith RN; Poindexter TP; Hansch C Physiol Chem Phys; 1975; 7(5):423-36. PubMed ID: 1197384 [TBL] [Abstract][Full Text] [Related]